Radiomics And Radiogenomics In Ovarian Cancer: A Review With A Focus On Ultrasound Applications

This review explores the potential of radiomics and radiogenomics, particularly through ultrasound applications, in enhancing the management of ovarian cancer (OC). These technologies, driven by artificial intelligence, aim to improve diagnostic accuracy and support personalized treatment by integrating imaging features with genomic data. Ultrasound-based radiomics offers real-time virtual biopsy capabilities and cost-effectiveness, aiding in differentiating tumor types and assessing metastatic risks. Despite challenges like standardizing imaging protocols and high costs, advancements in 3D ultrasound and therapeutic technologies could address these issues. The study emphasizes the need for structured frameworks and further validation in larger cohorts to fully realize the potential of ultrasound radiogenomics in precision oncology.